Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the national COVID cohort collaborative

Q Song, B Bates, YR Shao, FC Hsu, F Liu… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide real-world evidence on risks and outcomes of breakthrough COVID-
19 infections in vaccinated patients with cancer using the largest national cohort of COVID …

Association of COVID-19 vaccination with breakthrough infections and complications in patients with cancer

IY Gong, A Vijenthira, M Powis, A Calzavara… - JAMA …, 2023 - jamanetwork.com
Importance Patients with cancer are known to have increased risk of COVID-19
complications, including death. Objective To determine the association of COVID-19 …

[HTML][HTML] COVID-19 vaccination and breakthrough infections in patients with cancer

AL Schmidt, C Labaki, CY Hsu, Z Bakouny… - Annals of …, 2022 - Elsevier
Background Vaccination is an important preventive health measure to protect against
symptomatic and severe COVID-19. Impaired immunity secondary to an underlying …

[HTML][HTML] Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

LYW Lee, T Starkey, MC Ionescu, M Little… - The Lancet …, 2022 - thelancet.com
Background People with cancer are at increased risk of hospitalisation and death following
infection with SARS-CoV-2. Therefore, we aimed to conduct one of the first evaluations of …

Breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in vaccinated patients with cancer in the US between December 2020 and November 2021

W Wang, DC Kaelber, R Xu, NA Berger - JAMA oncology, 2022 - jamanetwork.com
Importance Limited data have been presented to examine breakthrough SARS-CoV-2
infections, hospitalizations, and mortality in vaccinated patients with cancer in the US …

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study …

TK Choueiri, C Labaki, Z Bakouny, CY Hsu… - The Lancet Regional …, 2023 - thelancet.com
Summary Background Breakthrough SARS-CoV-2 infections following vaccination against
COVID-19 are of international concern. Patients with cancer have been observed to have …

Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis

A Sakuraba, A Luna, D Micic - Journal of hematology & oncology, 2022 - Springer
Purpose Patients with cancer have an increased risk of coronavirus disease 2019 (COVID-
19) and an attenuated responses to various vaccines. This meta-analysis aims to assess the …

Association of COVID-19 vaccination with SARS-CoV-2 infection in patients with cancer: a US nationwide veterans affairs study

JTY Wu, J La, W Branch-Elliman, LB Huhmann… - JAMA …, 2022 - jamanetwork.com
Importance Patients with cancer are at increased risk for severe COVID-19, but it is unknown
whether SARS-CoV-2 vaccination is effective for them. Objective To determine the …

[HTML][HTML] Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

DJ Pinato, D Ferrante, J Aguilar-Company… - European Journal of …, 2022 - Elsevier
Abstract Background Although SARS-CoV-2 vaccines immunogenicity in patients with
cancer has been investigated, whether they can significantly improve the severity of COVID …

[HTML][HTML] Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis

AS Mai, ARYB Lee, RYK Tay, L Shapiro… - European Journal of …, 2022 - Elsevier
Importance Patients with cancer have an increased risk of severe disease and mortality from
COVID-19, as the disease and antineoplastic therapy cause reduced vaccine …